Nevirapine induced Stevens Johnson syndrome. Journal of Pharmacovigilance and Drug Research, [S. l.], v. 1, n. 2, p. 35–38, 2020. Disponível em: https://test.jpadr.com/index.php/jpadr/article/view/15. Acesso em: 14 oct. 2026.